Lupin Pharmaceuticals Inc. has voluntarily recalled 3,096 bottles of Amlodipine Besylate Tablets (10 mg), a medication used to treat high blood pressure and chest pain, because the tablets were found to be subpotent during a stability test. The recall affects 1000-count bottles under the Lupin brand with lot number A102887 and an expiration date of June 2023. No incidents or injuries have been reported to date regarding this issue.
A subpotent drug contains less than the required amount of active ingredient, which may make the medication less effective at managing blood pressure. If blood pressure is not properly controlled, patients may face an increased risk of heart-related complications.
You have 2 options:
Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD; Manufactured by Lupin Limited, Aurangabad, India.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.